UBS Group’s Pharming Group PHAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10
| Closed | -$101 | – | 9156 |
|
|
2024
Q4 | $101 | Buy |
+10
| New | +$101 | ﹤0.01% | 8403 |
|
|
2024
Q3 | – | Sell |
-789
| Closed | -$6.59K | – | 8642 |
|
|
2024
Q2 | $6.59K | Buy |
789
+737
| +1,417% | +$6.15K | ﹤0.01% | 6748 |
|
|
2024
Q1 | $546 | Buy |
+52
| New | +$546 | ﹤0.01% | 7313 |
|
|
2023
Q2 | – | Sell |
-881
| Closed | -$11.9K | – | 8258 |
|
|
2023
Q1 | $11.9K | Sell |
881
-370
| -30% | -$5K | ﹤0.01% | 6376 |
|
|
2022
Q4 | $13.8K | Sell |
1,251
-283
| -18% | -$3.12K | ﹤0.01% | 6948 |
|
|
2022
Q3 | $15K | Buy |
1,534
+62
| +4% | +$606 | ﹤0.01% | 6724 |
|
|
2022
Q2 | $13K | Buy |
1,472
+210
| +17% | +$1.86K | ﹤0.01% | 6498 |
|
|
2022
Q1 | $11K | Sell |
1,262
-66
| -5% | -$575 | ﹤0.01% | 7259 |
|
|
2021
Q4 | $12K | Buy |
1,328
+1,214
| +1,065% | +$11K | ﹤0.01% | 7447 |
|
|
2021
Q3 | $1K | Sell |
114
-1,205
| -91% | -$10.6K | ﹤0.01% | 8063 |
|
|
2021
Q2 | $15K | Sell |
1,319
-1,189
| -47% | -$13.5K | ﹤0.01% | 6547 |
|
|
2021
Q1 | $32K | Buy |
2,508
+1,592
| +174% | +$20.3K | ﹤0.01% | 5946 |
|
|
2020
Q4 | $14K | Buy |
+916
| New | +$14K | ﹤0.01% | 6199 |
|